跳至主要内容
临床试验/IRCT20240309061221N1
IRCT20240309061221N1已完成2 期

Evaluation of factors that affect the response to Etanercept and Adalimumab in treatment of Joint involvement in patients with Spondyloarthropathy and Rheumathoid Arthritis reffered to rheumatology clinics in Hamedan

Hamedan University of Medical Sciences0 个研究点目标入组 148 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
148

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • All patients with a definitive diagnosis of rheumatoid arthritis or spondyloarthropathy who are candidates for receiving anti-TNF drugs.

排除标准

  • The existence of contraindications for the administration of anti-TNF (history of MS, unexplained pancytopenia, heart failure class 2 and higher, presence of active infection, etc.)
  • The patient's unwillingness to cooperate
  • Inability to pay for medication

研究者

相似试验